INCB001158

· Incyte Corporation

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for INCB001158, covering 2020-05-21 to 2023-12-07. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors [Phase 1, Phase 2]